Printer Friendly
The Free Library
19,607,053 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Dates Announced for 2007 Sprint for Cancer @ Atlantic Station.


"Every Runner Has a Story" Theme for Fifth Annual Road Race Benefiting Georgia Cancer Foundation

ATLANTA -- The Radiant radiant: see meteor shower.  Charity Corporation (RCC RCC - An extensible language. ) recently announced the date and theme for the 2007 Sprint for Cancer @ Atlantic Station road race. The 2007 race will take place in the Atlantic Station district of Midtown Atlanta should be added to this article, to conform with Wikipedia's Manual of Style.
Please discuss this issue on the talk page.
 on April 29, with the theme, "Every Runner Has a Story."

The Sprint for Cancer @ Atlantic Station is a 5K and 10K charity road race put on by RCC, the non-profit charitable giving arm of Alpharetta-based Radiant Systems, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: RADS RADS Reactive Airways Dysfunction Syndrome (type of occupational asthma)
RADS Reynolds Adolescent Depression Scale
RADS República Árabe Democrática Saharaui
). One hundred percent of this year's proceeds will benefit the Georgia Cancer Foundation (GCF gcf
abbr.
greatest common factor
). The race is planned entirely by Radiant Systems' employees, who volunteer their time to be part of the event and execute all race logistics with the assistance of other volunteers and sponsors. Last year's race raised more than $60,000.

"Our theme for 2007, 'Every Runner Has a Story,' recognizes the intense personal nature of each runner's motivation, which parallels the dedication of the Georgia Cancer Foundation to provide cancer outreach Outreach is an effort by an organization or group to connect its ideas or practices to the efforts of other organizations, groups, specific audiences or the general public.  and personal support to patients and families affected by cancer," said Chris Lybeer, President of Radiant's retail division and Chairman of GCF. "As we prepare for this year's race, we recognize the courage of our friends, neighbors, and coworkers who have been affected."

"It's great to be kicking off our fifth year of partnership with Radiant in this charity road race," said Rudy Morgan, Executive Director of GCF. "This event raises much-needed money for programs dedicated to improving the quality of life for Georgia's cancer patients and families."

Interviews available upon request.

About the Radiant Charity Corporation

Founded in 2003 as a not-for-profit, 501(c)(3) organization, the Radiant Charity Corporation serves as the principal charitable giving vehicle for Radiant Systems and its employees. Since 2003 the Radiant Charity Corporation has raised more than $220,000 through the donations and fundraising
"Contributions" redirects here. For information about the Wikipedia user contributions log, see .
Fundraising
 activities of Radiant Systems and its employees. More information about The 2007 Sprint for Cancer @ Atlantic Station can be found online at www.sprintforcancer.com.

About the Georgia Cancer Foundation

Georgia Cancer Foundation (www.gacancerfoundation.org), based in Atlanta, is dedicated to improving the quality of life for cancer patients and their families through education, early detection, and support. The Foundation's innovative programs benefit Georgia residents who are affected by all types of cancer.

About Radiant Systems, Inc.

Radiant Systems, Inc. (www.radiantsystems.com) is a leader in providing innovative technology to the hospitality and retail industries. Offering unmatched reliability and ease of use, Radiant's hardware and software products have been deployed in over 60,000 sites across more than 100 countries. Radiant has approximately 1,000 employees worldwide, 325 certified See certification.  sales and service partners and over 1800 field service representatives. Founded in 1985, the company is headquartered in Atlanta with regional offices throughout the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area.  as well as in Europe, Asia and Australia.

Certain statements contained in this press release are "forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
" within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995, such as statements relating to relating to relate prepconcernant

relating to relate prepbezüglich +gen, mit Bezug auf +acc 
 financial results and plans for future business development activities, and are thus prospective. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) the Company's financing plans; (ii) trends affecting the Company's financial condition or results of operations; including the ability to integrate the operations of acquired businesses; (iii) the Company's growth strategy and operating strategy; (iv) the Company's new or future product offerings, and (v) the declaration and payment of dividends. The words "may," "would," "could," "will," "expect," "estimate," "anticipate," "believe," "intend," "plans," and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements as a result of various factors. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are the Company's reliance on a small number of customers for a larger portion of its revenues, fluctuations in its quarterly results, ability to continue and manage its growth, liquidity and other capital resources issues, competition and the other factors discussed in detail in the Company's filings with the Securities and Exchange Commission.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 27, 2007
Words:755
Previous Article:CityView Increases Its Shareholding in Angolan Projects.
Next Article:Attachmate Announces Enhanced Solution for Legacy-to-SOA Integration.
Topics:



Related Articles
Novelix Announces Licensing of Cancer Compound to AOP Orphan Pharmaceuticals.
Abraxis BioScience Reports Record Revenue of $765 Million in 2006 Versus $521 Million for 2005.
IDM Pharma Announces the Completion of Enrollment in Two Phase II Trials of Uvidem(R) in Melanoma.
Pro-Pharmaceuticals Submits Orphan Drug Status Application to European Medicines Agency Co-administration of DAVANAT(R) with 5-FU to Treat...
BioSphere Medical Highlights a Scheduled Presentation and Abstracts at the 2007 SIR 32nd Annual Scientific Meeting.
Pro-Pharmaceuticals Announces Third Site Dosing Patients with DAVANAT(R) in Phase II, First Line, Colorectal Cancer Clinical Trial.
Sprint Nextel Declares First Quarter Dividends.
Cytogen Announces Initiation of Phase 1 Trial for Radiolabeled Antibody for the Treatment of Hormone-Refractory Prostate Cancer.
Point Therapeutics Provides Clinical Update.
Sprint Nextel Schedules Second Quarter 2007 Earnings Release and Conference Call.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles